T. Gunduz Et Al. , "Cladribine treatment in turkish MS patients," 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis , Amsterdam, Netherlands, pp.889-890, 2022
Gunduz, T. Et Al. 2022. Cladribine treatment in turkish MS patients. 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis , (Amsterdam, Netherlands), 889-890.
Gunduz, T., Koseoglu, M., Ozen, P. A., Tutuncu, M., Uzunkopru, C., Demir, S., ... Gumus, H.(2022). Cladribine treatment in turkish MS patients . 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (pp.889-890). Amsterdam, Netherlands
Gunduz, Tuncay Et Al. "Cladribine treatment in turkish MS patients," 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam, Netherlands, 2022
Gunduz, Tuncay Et Al. "Cladribine treatment in turkish MS patients." 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis , Amsterdam, Netherlands, pp.889-890, 2022
Gunduz, T. Et Al. (2022) . "Cladribine treatment in turkish MS patients." 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis , Amsterdam, Netherlands, pp.889-890.
@conferencepaper{conferencepaper, author={Tuncay GÜNDÜZ Et Al. }, title={Cladribine treatment in turkish MS patients}, congress name={38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis}, city={Amsterdam}, country={Netherlands}, year={2022}, pages={889-890} }